Presence, formation and putative biological activities of N-acyl serotonins, a novel class of fatty-acid derived mediators, in the intestinal tract

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1811, Issue 10, 2011, Pages 578-586

  Verhoeckx, Kitty C M ^a   Voortman, Trudy ^a,b   Balvers, Michiel G J ^a,b   Hendriks, Henk F J ^a   M wortelboer, Heleen ^a   Witkamp, Renger F ^b  

^a TNO   (Netherlands)

^b WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

FAAH; Fish oil; Gastro intestinal tract; GLP 1; N acyl serotonin

Indexed keywords

DOCOSAHEXAENOIC ACID; FATTY ACID AMIDASE INHIBITOR; FATTY ACID DERIVATIVE; GLUCAGON LIKE PEPTIDE 1; PALMITOYL COENZYME A; PUTATIVE NEUROTRANSMITTER; SEROTONIN; STEAROYL COENZYME A;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; FAT INTAKE; GASTROINTESTINAL TRACT; ILEUM; IN VITRO STUDY; JEJUNUM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; FATTY ACIDS; INTESTINES; MALE; MICE; SEROTONIN; SWINE; TANDEM MASS SPECTROMETRY;

MUS; SUIDAE;

EID: 79961105328     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2011.07.008     Document Type: Article

References (41)

1. C. Ezzili, K. Otrubova, and D.L. Boger Fatty acid amide signaling molecules Bioorg. Med. Chem. Lett. 20 2010 5959 5968
2. S.P. Alexander, and D.A. Kendall The complications of promiscuity: endocannabinoid action and metabolism Br. J. Pharmacol. 152 2007 602 623 (Pubitemid 350034984)
3. F. Borrelli, and A.A. Izzo Role of acylethanolamides in the gastrointestinal tract with special reference to food intake and energy balance Best Pract. Res. Clin. Endocrinol. Metab. 23 2009 33 49
4. V. Di Marzo, T. Bisogno, and L. De Petrocellis Endocannabinoids and related compounds: walking back and forth between plant natural products and animal physiology Chem. Biol. 14 2007 741 756 (Pubitemid 47081420)
5. S. Burstein The elmiric acids: biologically active anandamide analogs Neuropharmacology 55 2008 1259 1264
6. B. Tan, D.K. O'Dell, Y.W. Yu, M.F. Monn, H.V. Hughes, S. Burstein, and J.M. Walker Identification of endogenous acyl amino acids based on a targeted lipidomics approach J. Lipid Res. 51 2010 112 119
7. B. Tan, Y.W. Yu, M.F. Monn, H.V. Hughes, D.K. O'Dell, and J.M. Walker Targeted lipidomics approach for endogenous N-acyl amino acids in rat brain tissue J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877 2009 2890 2894
8. S.H. Burstein, J.K. Adams, H.B. Bradshaw, C. Fraioli, R.G. Rossetti, R.A. Salmonsen, J.W. Shaw, J.M. Walker, R.E. Zipkin, and R.B. Zurier Potential anti-inflammatory actions of the elmiric (lipoamino) acids Bioorg. Med. Chem. 15 2007 3345 3355 (Pubitemid 46529271)
9. C.J. Chu, S.M. Huang, L. De Petrocellis, T. Bisogno, S.A. Ewing, J.D. Miller, R.E. Zipkin, N. Daddario, G. Appendino, V. Di Marzo, and J.M. Walker N-oleoyldopamine, a novel endogenous capsaicin-like lipid that produces hyperalgesia J. Biol. Chem. 278 2003 13633 13639 (Pubitemid 36799898)
10. S.M. Huang, T. Bisogno, M. Trevisani, A. Al-Hayani, L. De Petrocellis, F. Fezza, M. Tognetto, T.J. Petros, J.F. Krey, C.J. Chu, J.D. Miller, S.N. Davies, P. Geppetti, J.M. Walker, and V. Di Marzo An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors Proc. Natl. Acad. Sci. U.S.A. 99 2002 8400 8405 (Pubitemid 34651064)
11. L. De Petrocellis, C.J. Chu, A.S. Moriello, J.C. Kellner, J.M. Walker, and V. Di Marzo Actions of two naturally occurring saturated N-acyldopamines on transient receptor potential vanilloid 1 (TRPV1) channels Br. J. Pharmacol. 143 2004 251 256 (Pubitemid 39315145)
12. Z.L. Chu, C. Carroll, J. Alfonso, V. Gutierrez, H. He, A. Lucman, M. Pedraza, H. Mondala, H. Gao, D. Bagnol, R. Chen, R.M. Jones, D.P. Behan, and J. Leonard A role for intestinal endocrine cell-expressed g protein-coupled receptor 119 in glycemic control by enhancing glucagon-like Peptide-1 and glucose-dependent insulinotropic Peptide release Endocrinology 149 2008 2038 2047 (Pubitemid 351574507)
13. L.M. Lauffer, R. Iakoubov, and P.L. Brubaker GPR119 is essential for oleoylethanolamide-induced glucagon-like peptide-1 secretion from the intestinal enteroendocrine L-cell Diabetes 58 2009 1058 1066
14. H.A. Overton, M.C. Fyfe, and C. Reynet GPR119, a novel G protein-coupled receptor target for the treatment of type 2 diabetes and obesity Br. J. Pharmacol. 153 Suppl 1 2008 S76 S81
15. Z.L. Chu, C. Carroll, R. Chen, J. Alfonso, V. Gutierrez, H. He, A. Lucman, C. Xing, K. Sebring, J. Zhou, B. Wagner, D. Unett, R.M. Jones, D.P. Behan, and J. Leonard N-oleoyldopamine enhances glucose homeostasis through the activation of GPR119 Mol. Endocrinol. 24 2010 161 170
16. S. Batkai, D. Osei-Hyiaman, H. Pan, O. El-Assal, M. Rajesh, P. Mukhopadhyay, F. Hong, J. Harvey-White, A. Jafri, G. Hasko, J.W. Huffman, B. Gao, G. Kunos, and P. Pacher Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury FASEB J. 21 2007 1788 1800 (Pubitemid 46855625)
17. M.G. Balvers, K.C. Verhoeckx, P. Plastina, H.M. Wortelboer, J. Meijerink, and R.F. Witkamp Docosahexaenoic acid and eicosapentaenoic acid are converted by 3 T3-L1 adipocytes to N-acyl ethanolamines with anti-inflammatory properties Biochim. Biophys. Acta 1801 2010 1107 1114
18. T. Bisogno, D. Melck, L. De Petrocellis, M. Bobrov, N.M. Gretskaya, V.V. Bezuglov, N. Sitachitta, W.H. Gerwick, and V. Di Marzo Arachidonoylserotonin and other novel inhibitors of fatty acid amide hydrolase Biochem. Biophys. Res. Commun. 248 1998 515 522 (Pubitemid 28404452)
19. S. Pillarisetti, C.W. Alexander, and I. Khanna Pain and beyond: fatty acid amides and fatty acid amide hydrolase inhibitors in cardiovascular and metabolic diseases Drug Discov. Today 14 2009 1098 1111
20. P.P. Bertrand, and R.L. Bertrand Serotonin release and uptake in the gastrointestinal tract Auton. Neurosci. 153 2010 47 57
21. M.D. Gershon, and J. Tack The serotonin signaling system: from basic understanding to drug development for functional GI disorders Gastroenterology 132 2007 397 414 (Pubitemid 46127672)
22. A. Sikander, S.V. Rana, and K.K. Prasad Role of serotonin in gastrointestinal motility and irritable bowel syndrome Clin. Chim. Acta 403 2009 47 55
23. P.G. McLean, R.A. Borman, and K. Lee 5-HT in the enteric nervous system: gut function and neuropharmacology Trends Neurosci. 30 2007 9 13 (Pubitemid 46001679)
24. M.G. Balvers, K.C. Verhoeckx, and R.F. Witkamp Development and validation of a quantitative method for the determination of 12 endocannabinoids and related compounds in human plasma using liquid chromatography-tandem mass spectrometry J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877 2009 1583 1590
25. D. Richardson, C.A. Ortori, V. Chapman, D.A. Kendall, and D.A. Barrett Quantitative profiling of endocannabinoids and related compounds in rat brain using liquid chromatography-tandem electrospray ionization mass spectrometry Anal. Biochem. 360 2007 216 226 (Pubitemid 44958332)
26. J.T. Wood, J.S. Williams, L. Pandarinathan, A. Courville, M.R. Keplinger, D.R. Janero, P. Vouros, A. Makriyannis, and C.J. Lammi-Keefe Comprehensive profiling of the human circulating endocannabinoid metabolome: clinical sampling and sample storage parameters Clin. Chem. Lab. Med. 46 2008 1289 1295
27. J. Palandra, J. Prusakiewicz, J.S. Ozer, Y. Zhang, and T.G. Heath Endogenous ethanolamide analysis in human plasma using HPLC tandem MS with electrospray ionization J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877 2009 2052 2060
28. J. Williams, J. Wood, L. Pandarinathan, D.A. Karanian, B.A. Bahr, P. Vouros, and A. Makriyannis Quantitative method for the profiling of the endocannabinoid metabolome by LC-atmospheric pressure chemical ionization-MS Anal. Chem. 79 2007 5582 5593 (Pubitemid 47229803)
29. A. Artmann, G. Petersen, L.I. Hellgren, J. Boberg, C. Skonberg, C. Nellemann, S.H. Hansen, and H.S. Hansen Influence of dietary fatty acids on endocannabinoid and N-acylethanolamine levels in rat brain, liver and small intestine Biochim. Biophys. Acta 1781 2008 200 212
30. J.T. Wood, J.S. Williams, L. Pandarinathan, D.R. Janero, C.J. Lammi-Keefe, and A. Makriyannis Dietary docosahexaenoic acid supplementation alters select physiological endocannabinoid-system metabolites in brain and plasma J. Lipid Res. 51 2010 1416 1423
31. P. Tso, A. Nauli, and C.M. Lo Enterocyte fatty acid uptake and intestinal fatty acid-binding protein Biochem. Soc. Trans. 32 2004 75 78 (Pubitemid 38283017)
32. M. Bifulco, C. Laezza, M. Valenti, A. Ligresti, G. Portella, and V. Di Marzo A new strategy to block tumor growth by inhibiting endocannabinoid inactivation FASEB J. 18 2004 1606 1608 (Pubitemid 39561648)
33. B. Costa, I. Bettoni, S. Petrosino, F. Comelli, G. Giagnoni, and V. Di Marzo The dual fatty acid amide hydrolase/TRPV1 blocker, N-arachidonoyl- serotonin, relieves carrageenan-induced inflammation and hyperalgesia in mice Pharmacol. Res. 61 2010 537 546
34. G. D'Argenio, M. Valenti, G. Scaglione, V. Cosenza, I. Sorrentini, and V. Di Marzo Up-regulation of anandamide levels as an endogenous mechanism and a pharmacological strategy to limit colon inflammation FASEB J. 20 2006 568 570 (Pubitemid 46671252)
35. E. de Lago, S. Petrosino, M. Valenti, E. Morera, S. Ortega-Gutierrez, J. Fernandez-Ruiz, and V. Di Marzo Effect of repeated systemic administration of selective inhibitors of endocannabinoid inactivation on rat brain endocannabinoid levels Biochem. Pharmacol. 70 2005 446 452 (Pubitemid 40905116)
36. V. de Novellis, E. Palazzo, F. Rossi, L. De Petrocellis, S. Petrosino, F. Guida, L. Luongo, A. Migliozzi, L. Cristino, I. Marabese, K. Starowicz, V. Di Marzo, and S. Maione The analgesic effect of N-arachidonoyl-serotonin, a FAAH inhibitor and TRPV1 receptor antagonist, associated with changes in rostral ventromedial medulla and locus coeruleus cell activity in rats Neuropharmacology 55 2008 1105 1113
37. C.J. Fowler, G. Tiger, M.L. Lopez-Rodriguez, A. Viso, S. Ortega-Gutierrez, and J.A. Ramos Inhibition of fatty acid amidohydrolase, the enzyme responsible for the metabolism of the endocannabinoid anandamide, by analogues of arachidonoyl-serotonin J. Enzyme Inhib. Med. Chem. 18 2003 225 231 (Pubitemid 36827034)
38. S. Maione, L. De Petrocellis, V. de Novellis, A.S. Moriello, S. Petrosino, E. Palazzo, F.S. Rossi, D.F. Woodward, and V. Di Marzo Analgesic actions of N-arachidonoyl-serotonin, a fatty acid amide hydrolase inhibitor with antagonistic activity at vanilloid TRPV1 receptors Br. J. Pharmacol. 150 2007 766 781 (Pubitemid 46440215)
39. G. Ortar, M.G. Cascio, L. De Petrocellis, E. Morera, F. Rossi, A. Schiano-Moriello, M. Nalli, V. de Novellis, D.F. Woodward, S. Maione, and V. Di Marzo New N-arachidonoylserotonin analogues with potential "dual" mechanism of action against pain J. Med. Chem. 50 2007 6554 6569 (Pubitemid 350309095)
40. K. Diepvens, D. Haberer, and M. Westerterp-Plantenga Different proteins and biopeptides differently affect satiety and anorexigenic/orexigenic hormones in healthy humans Int. J. Obes. (Lond) 32 2008 510 518 (Pubitemid 351414824)
41. A. Hirasawa, K. Tsumaya, T. Awaji, S. Katsuma, T. Adachi, M. Yamada, Y. Sugimoto, S. Miyazaki, and G. Tsujimoto Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120 Nat. Med. 11 2005 90 94 (Pubitemid 40215843)